H

    Health Catalyst Inc (HCAT)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $1.64
    +0.05 (+3.14%)

    Market Cap: $119.66M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    79%(23/29)
    Avg Surprise
    +72.59%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.05
    Range$-0.08 - $-0.02
    5 analysts
    EPS RevisionsNo revisions (7d)
    0
    3
    30d
    EPS Estimate Drift
    90d ago$-0.00+99.3%
    60d ago$-0.00+99.3%
    30d ago$-0.00+99.3%
    7d ago$-0.05+1.7%
    Current$-0.05
    Revenue Consensus
    $55M
    Range$55M - $56M
    6 analysts
    Dec 31, 2026
    EPS Consensus$-0.03
    Range$-0.07 - $0.01
    5 analysts
    Revenue Consensus
    $54M
    Range$52M - $57M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.03---
    Sep 26EST
    		-$-0.05---
    Jun 26
    		$-0.08$-0.05-60.00%Miss+0.0%
    Mar 26
    		$0.02$0.01+100.00%Beat+100.0%
    Dec 25
    		$0.08$0.10-16.14%Miss+100.0%
    Sep 25
    		$0.06$0.07-14.29%Miss-14.3%
    Jun 25
    		$-0.08$-0.09+11.11%Beat-166.7%
    Mar 25
    		$0.01N/A-66.67%Miss-80.0%
    Dec 24
    		$0.04$0.08-47.64%Miss+100.0%
    Sep 24
    		$0.07$0.09-22.22%Miss+133.3%
    Jun 24
    		$0.12$0.08+50.00%Beat+140.0%
    Mar 24
    		$0.05$0.03+66.67%Beat+0.0%
    Dec 23
    		$0.02$-0.01+300.00%Beat+140.0%
    Sep 23
    		$0.03$-0.01+400.00%Beat+123.1%
    Jun 23
    		$0.05$-0.01+600.00%Beat+266.7%
    Mar 23
    		$0.05$-0.04+225.00%Beat+183.3%
    Dec 22
    		$-0.05N/A+54.55%Beat+73.7%
    Sep 22
    		$-0.13$-0.19+31.58%Beat+27.8%
    Jun 22
    		$-0.03N/A+66.67%Beat-1664.7%
    Mar 22
    		$-0.06$-0.11+45.45%Beat+0.0%
    Dec 21
    		$-0.19$-0.21+9.52%Beat-18.8%
    Sep 21
    		$-0.18$-0.22+18.18%Beat+14.3%
    Jun 21
    		$-0.00N/A+98.79%Beat+98.9%
    Mar 21
    		$-0.06N/A+57.14%Beat+62.5%
    Dec 20
    		$-0.16$-0.19+15.79%Beat+23.8%
    Sep 20
    		$-0.21$-0.27+22.22%Beat+22.2%
    Jun 20
    		$-0.15$-0.22+31.82%Beat+28.6%
    Mar 20
    		$-0.16$-0.26+38.46%Beat+92.6%
    Dec 19
    		$-0.21$-0.29+27.59%Beat-
    Sep 19
    		$-0.27$-0.37+27.03%Beat-
    Jun 19
    		$-0.21$-0.32+34.38%Beat-
    Mar 19
    		$-2.17$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio20.50EV/EBITDA-4.96x
    Price/FCF4.49xFCF Yield22.28%
    Profitability
    Profit Margin-90.60%Operating Margin-5.35%
    ROE-118.10%ROIC-96.95%
    Financial Health
    Debt/Equity1.52xInterest Coverage-14.40x
    Current Ratio2.70xQuick Ratio2.70x
    Trading Statistics
    Beta1.56Avg Volume930.28K
    52-Week High$3.6252-Week Low$0.95

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.61
    SMA 20$1.77
    SMA 50$1.97
    SMA 200$1.87
    EMA 10$1.64
    EMA 20$1.74
    EMA 50$1.83
    EMA 200$2.04

    MACD

    Line: -0.12Signal: -0.11Hist: -0.01

    ADX

    ADX: 22.8+DI: 16.5-DI: 26.5

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down80.0
    PSAR$2.03

    Bollinger Bands

    Upper Band$2.28
    Lower Band$1.26
    %B Position5728%(Upper)
    Band Width0.37

    RSI (14-Day)

    Neutral
    40.4

    Momentum Oscillators

    Stoch %K21.6
    Stoch %D17.2
    Williams %R-69.0
    ROC (10d)-3.5%
    Momentum-0.06
    CCI (20d)-65.5
    MFI (14d)59.0

    Volatility Measures

    ATR (14d)$0.11(6.9%)
    StdDev (20d)0.25
    Hist Vol105.2%(High)

    Volume Flow

    VWAP$1.62
    OBV5.4M
    AD Line-2.6M
    CMF (20d)-0.152

    Volume Metrics

    Avg Vol (20d)939.5K
    Vol Ratio0.3x(Low)
    VWMA (20d)$1.83

    Pivot Points

    R3$1.68
    R2$1.66
    R1$1.63
    Pivot Point$1.60
    S1$1.57
    S2$1.55
    S3$1.51

    Advanced Oscillators

    TSI-24.44
    Ultimate Osc40.8
    KST-225.68

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$70.49M$70.76M$74.68M$76.32M$80.72M$79.41M$79.61M$76.35M$75.90M$74.72M$75.08M$73.77M
    Cost of Revenue$35.63M$35.29M$35.30M$38.51M$42.48M$43.18M$44.91M$42.31M$40.06M$38.52M$44.58M$41.79M
    Gross Profit$34.86M$35.46M$39.38M$37.82M$38.24M$36.23M$34.69M$34.04M$35.84M$36.21M$30.51M$31.99M
    Operating Expenses$71.34M$141.94M$125.46M$55.33M$75.33M$56.41M$52.19M$47.73M$51.65M$59.02M$63.29M$56.57M
    R&D$11.03M$9.78M$9.91M$12.28M$12.39M$15.19M$15.00M$14.19M$13.88M$14.87M$20.29M$17.67M
    SG&A$11.93M$13.96M$11.04M$16.07M$8.28M$14.16M$15.68M$12.21M$14.36M$14.56M$15.43M$13.63M
    Operating Income$-36,480,000$-106,477,000$-86,080,000$-17,509,000$-37,094,000$-20,171,000$-17,500,000$-13,687,000$-15,807,000$-22,812,000$-32,785,000$-24,580,000
    Interest Income$-3,742,000$-4,135,000$-4,566,000$-4,679,000$-3,803,000$-3,356,000$-2,548,000$-1,514,000$2.36M$2.34M$2.62M$2.61M
    Interest Expense$3.74M$4.13M$4.57M$4.68M$3.80M$3.36M$2.55M$1.51M$0$0$0$0
    Income Before Tax$-40,222,000$-110,612,000$-90,646,000$-22,188,000$-40,897,000$-23,527,000$-20,048,000$-15,201,000$-13,446,000$-20,474,000$-30,169,000$-21,973,000
    Income Tax Expense$315,000$414,000$379,000$41,000$81,000$215,000$625,000$-475,000$70,000$113,000$143,000$59,000
    Net Income$-40,537,000$-111,026,000$-91,025,000$-22,229,000$-40,978,000$-23,742,000$-20,673,000$-14,726,000$-13,516,000$-20,587,000$-30,312,000$-22,032,000
    EBITDA$-25,255,000$-93,956,000$-72,666,000$-4,423,000$-23,548,000$-7,557,000$-6,914,000$-3,136,000$-5,953,000$-13,873,000$-25,006,000$-16,829,000
    EBIT$-36,480,000$-106,477,000$-86,080,000$-17,509,000$-37,094,000$-20,171,000$-17,500,000$-13,687,000$-15,807,000$-22,812,000$-32,785,000$-24,580,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HCAT

    News

    Health Catalyst Shares Fall After Canaccord Genuity Downgrade

    Health Catalyst (HCAT) shares fell following a downgrade by Canaccord Genuity from "Buy" to "Hold." The analyst firm also reduced its price target for HCAT to $1.80 from $3.00, contributing to the stock's decline.

    marketscreener.com•8/21/26•
    Bearish

    HCAT Downgraded by Canaccord Genuity -- Price Target Lowered to $1.80

    Health Catalyst (HCAT) has been downgraded by Canaccord Genuity from 'Buy' to 'Hold', with its price target significantly reduced from $3.00 to $1.80. Despite a GuruFocus GF Value™ indicating the stock is 60.3% undervalued at $4.11, the company's low profitability and valuation ranks, coupled with mixed institutional investor sentiment and no recent insider activity, suggest caution for potential investors.

    GuruFocus•8/21/26•
    Bearish

    Health Catalyst, GitLab, Elastic, and Marqeta Shares Plummet, What You Need To Know

    Shares of Health Catalyst, GitLab, Elastic, and Marqeta experienced significant drops after a Bloomberg report indicated Anthropic's Q2 revenue exceeded $11.5 billion, suggesting AI tools are gaining traction and potentially impacting software companies. This market reaction intensified existing pressure on software stocks, raising concerns about customers shifting budgets to AI assistants. Health Catalyst, in particular, saw a 7% decline, adding to its previous drop due to a weak Q3 revenue forecast and lowered full-year guidance.

    Yahoo Finance•8/18/26•
    Bearish

    Health Catalyst (HCAT) group led by Clint Coghill reports 9.6% ownership stake

    A group of investment entities associated with Clint D. Coghill has reported a 9.6% ownership stake in Health Catalyst (HCAT) as of June 30, 2026. This includes direct holdings by Stoney Lonesome HF LP and Drake Helix Holdings, LLC. Clint D. Coghill and CDC Financial, Inc. are deemed to beneficially own a total of 7,095,498 shares, representing this 9.6% of outstanding shares.

    Stock Titan•8/14/26•
    Neutral

    HCAT Maintains by Wells Fargo -- Price Target Lowered to $1.50

    Wells Fargo has maintained an Equal-Weight rating for Health Catalyst (HCAT) but lowered its price target to $1.50 from $1.75, citing concerns over growth expectations in a challenging healthcare environment. Despite this, GuruFocus assesses HCAT as 57.3% undervalued with a GF Value™ of $4.16 against a current price of $1.77, though its GF Score™ of 52/100 points to challenges in profitability and financial strength. Investors are advised to proceed with caution due to ongoing losses and cash flow issues, despite the perceived undervaluation.

    GuruFocus•8/13/26•
    Somewhat-Bearish

    Frequently Asked Questions About HCAT

    Does HCAT pay dividends?
    Health Catalyst Inc (HCAT) does not currently pay a regular dividend.
    What is HCAT's P/E ratio?
    Health Catalyst Inc has a price-to-earnings (P/E) ratio of 20.50.
    What is HCAT's market cap?
    Health Catalyst Inc (HCAT) has a market capitalization of $119.66M with a current stock price of $1.64.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In